Skip to main content
Rural Health Information Hub

Impact of Telemedicine on Retention in Medications for Opioid Use Disorder (MOUD) Treatment With Buprenorphine in the Times of COVID-19 Pandemic: A Retrospective Chart Review

Description
Study examining treatment retention for Medication for Opioid Use Disorder (MOUD) patients via telehealth during the COVID-19 pandemic, based on electronic health records of patients at a rural Federally Qualified Health Center (FQHC) in Pennsylvania. Discusses the impacts of telemedicine on retention rates, COVID-19-related challenges to treatment delivery systems, and policy measures to support telehealth and MOUD interventions.
Author(s)
Jagdeep Kaur, Irakli Mania, Raghavendra Tirupathi, Lakshmi Polavarapu
Citation
Journal of Rural Mental Health, 46(2), 75-81
Date
04/2022
Type
Document
Tagged as
Illicit drug use · Infectious diseases · Policy · Prescription drug misuse · Statistics and data · Telehealth · Pennsylvania